Zevra Therapeutics (ZVRA) Amortization - Intangibles (2023 - 2026)

Zevra Therapeutics' Amortization - Intangibles history runs 4 years deep, the most recent figure standing at $316000.0 for Q1 2026.

• Quarterly Amortization - Intangibles fell 80.43% year-over-year to $316000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (down 59.46% YoY) and the FY2025 annual result came in at $3.9 million, down 38.06% from the prior year.
• Amortization - Intangibles was $316000.0 for Q1 2026 at Zevra Therapeutics, roughly flat from $316000.0 in the prior quarter.
• Across five years, Amortization - Intangibles topped out at $1.6 million in Q4 2024 and bottomed at $315000.0 in Q3 2025.
• A 4-year average of $1.1 million and a median of $1.5 million in 2024 frame the typical range for Amortization - Intangibles.
• Annual changes were most pronounced in 2024 — Amortization - Intangibles soared 109.33% — and 2025, when it tumbled 80.45%.
• Zevra Therapeutics' Amortization - Intangibles stood at $772000.0 in 2023, then soared by 109.33% to $1.6 million in 2024, then tumbled by 80.45% to $316000.0 in 2025, then changed by 0.0% to $316000.0 in 2026.
• Business Quant data shows ZVRA's Amortization - Intangibles at $316000.0 in Q1 2026, $316000.0 in Q4 2025, and $315000.0 in Q3 2025.